Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Ocrelizumab may cause delayed hair loss in some patients.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Etretinate treatment changed hair growth patterns in many patients.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Tofacitinib taken by mouth helps treat hair loss in children.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

New treatments for lupus show promise, but more research is needed, especially for children.

A woman with bullous pemphigoid had an allergic reaction to azathioprine, but got better with alternative treatments.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Ustekinumab helped three kids with alopecia areata regrow hair.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.